首页 >
法规速递
-
Page: Ticagrelor product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Emtricitabine / rilpivirine / tenofovir disoproxil product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Rilpivirine product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: List of medicines under additional monitoring-2025/7/30
2025-07-31查看详情 > -
Page: Rivaroxaban product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Sitagliptin product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Tacrolimus granules product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Document: Fingolimod capsules 0.25 and 0.5 mg product-specific bioequivalence guidance-2025/7/29
2025-07-30查看详情 > -
Page: Clinical trials in human medicines-2025/7/29
2025-07-30查看详情 > -
Page: Website outages and upgrades-2025/7/29
2025-07-30查看详情 >